The number of people with type 2 diabetes is expected to be close to 600 million worldwide within the next 10 years, but whether the general public should undergo routine screening is a subject of debate.
Investigators studied whether combining anti-interleukin-21 antibody with liraglutide could enable β-cell survival with a reduced risk of complications compared with traditional immunomodulation.
Researchers performed a cross-sectional study of NHANES data to determine the prevalence of self-reported aspirin use among older adults for the prevention of cardiovascular disease.
